Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00843973 · ClinicalTrials.gov registry record
Osteogenic Cell Viability in Bone Graft
A clinical trial, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- 83
- Enrollment target
NCT00843973: Completed study, sponsored by University of Missouri-Columbia.
NCT00843973 is a clinical trial that has completed, run by University of Missouri-Columbia. The registered enrollment target is 83 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00843973 has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- 83 participants
- Enrollment target
Study Summary
The purpose of this study is to find out if the cells in bone graft samples collected using a reamer are similar to the cells in bone graft samples collected using the iliac crest bone graft method.
Interventions
- PROCEDURE iliac crest bone graft
- PROCEDURE Reamer Irrigator Aspirator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2008-06 |
| Est. Completion | 2013-12 |
What the finished NCT00843973 record still lists
NCT00843973 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 83 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which iliac crest bone graft is the first listed.
NCT00843973 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00843973 about?
NCT00843973 is a clinical study titled "Osteogenic Cell Viability in Bone Graft". The purpose of this study is to find out if the cells in bone graft samples collected using a reamer are similar to the cells in bone graft samples collected using the iliac crest bone graft method.
What is the current status of trial NCT00843973?
This trial is currently completed. The enrollment target is 83 participants. The study started on 2008-06. Estimated completion is 2013-12.
What interventions are being tested in trial NCT00843973?
The interventions under investigation include: iliac crest bone graft (PROCEDURE), Reamer Irrigator Aspirator (PROCEDURE).
Who is sponsoring clinical trial NCT00843973?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02974647 · 83 participants · Phase 2
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
- NCT03919292 · 83 participants · Phase 1
Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca
- NCT04626674 · 83 participants · Phase 1
A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)
- NCT05277168 · 83 participants · Phase 1
A Trial TO Evaluate THE Safety, Tolerability, Pharmacokinetics, AND Efficacy OF Shr-a1904 IN Subjects With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia